Industry News
Important Target Playing Role In Tobacco-Related Lung Cancers Discovered By Researchers
Feb 13, 2012
Researchers at Moffitt Cancer Center in Tampa, Fla., have discovered that the immune response regulator IKBKE (serine/threonine kinase) plays two roles in tobacco-related non-small cell lung cancers. Tobacco carcinogens induce IKBKE and, in turn, IKBKE induces chemotherapy resistance. The study was published in a recent issue of Oncogene... Read More
Cell Death Unleashes Full Force Of Human Antiviral System
Feb 13, 2012
A scientific team led by researchers at the University of Geneva (UNIGE) and the Charite Berlin Medical University has made a completely unprecedented discovery showing how much our immune system is provoked into action when confronted by viral intruders... Read More
Nanotube Therapy Takes Aim At Breast Cancer Stem Cells
Feb 13, 2012
Wake Forest Baptist Medical Center researchers have again proven that injecting multiwalled carbon nanotubes (MWCNTs) into tumors and heating them with a quick, 30-second laser treatment can kill them... Read More
Important Target Playing Role In Tobacco-Related Lung Cancers Discovered By Researchers
Feb 13, 2012
Researchers at Moffitt Cancer Center in Tampa, Fla., have discovered that the immune response regulator IKBKE (serine/threonine kinase) plays two roles in tobacco-related non-small cell lung cancers. Tobacco carcinogens induce IKBKE and, in turn, IKBKE induces chemotherapy resistance. The study was published in a recent issue of Oncogene... Read More
Childhood Leukemia Drug, Methotrexate, In Short Supply
Feb 12, 2012
Methotrexate, a drug used to treat acute lymphoblastic leukemia, the most common childhood leukemia, is now also in short supply in the USA, along with several other lifesaving drugs. According to the FDA, vital lifesaving hospital drugs have not been so scarce in ten years. Methotrexate works by slowing down the rate at which cancer cells grow... Read More
Childhood Leukemia Drug, Methotrexate, In Short Supply
Feb 12, 2012
Methotrexate, a drug used to treat acute lymphoblastic leukemia, the most common childhood leukemia, is now also in short supply in the USA, along with several other lifesaving drugs. According to the FDA, vital lifesaving hospital drugs have not been so scarce in ten years. Methotrexate works by slowing down the rate at which cancer cells grow... Read More
Gene Variants Make Some People More Susceptible To Colon Cancer
Feb 12, 2012
An international research team led by cell biologists at the University of California, Riverside has uncovered a new insight into colon cancer, the third leading cause of cancer-related deaths in the United States. The research provides potential new avenues for diagnosing and treating the disease... Read More
Discussions About End-Of-Life Care Between Physicians And Terminally Ill Cancer Patients Often Delayed Too Long
Feb 12, 2012
The vast majority of patients with incurable lung or colorectal cancer talk with a physician about their options for care at the end of life, but often not until late in the course of their illness, according to a new study by Dana-Farber Cancer Institute investigators published in the Annals of Internal Medicine... Read More
Study Of Acute Anemia Due To Postpartum Hemorrhage
Feb 12, 2012
In a study presented at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in Dallas, Texas, researchers reported findings that show that in women with acute postpartum anemia, due to excessive blood loss during delivery, red blood cell transfusion led to a statistically significant decrease in physical fatigue... Read More
Gene Variants Make Some People More Susceptible To Colon Cancer
Feb 12, 2012
An international research team led by cell biologists at the University of California, Riverside has uncovered a new insight into colon cancer, the third leading cause of cancer-related deaths in the United States. The research provides potential new avenues for diagnosing and treating the disease... Read More
Previous Page Next Page